The neuroAD system by Neuronix is an innovative, safe and effective non-pharmaceutical treatment alternative for mild to moderate Alzheimer’s Disease. It is the first medical device in the world cleared for this indication.
- Shown to slow the degenerative progression of Alzheimer’s Disease.
- Evidenced safe and effective in peer-reviewed studies
- Discovered to be superior to existing pharmaceuticals in the treatment of Alzheimer’s Disease
- Regulatory (CE) approved technology for “treatment of mild to moderate Alzheimer’s Disease”
- Known and described in literature mechanism of action
- Ongoing clinical trials in Alzheimer’s patients and active R&D
- Endorsed and backed by strong Scientific Advisory Board
- Clinical Data
In clinical trials, neuroAD technology has shown measurable cognitive improvement after just a few weeks. The results showed marked reversal of disease progression.